AMERICAN INTERNATIONAL GROUP, INC. - BRIDGEBIO PHARMA INC ownership

BRIDGEBIO PHARMA INC's ticker is BBIO and the CUSIP is 10806X102. A total of 75 filers reported holding BRIDGEBIO PHARMA INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.9%.

Quarter-by-quarter ownership
AMERICAN INTERNATIONAL GROUP, INC. ownership history of BRIDGEBIO PHARMA INC
ValueSharesWeighting
Q3 2023$1,507,204
-91.0%
57,156
-94.2%
0.01%
-90.3%
Q2 2023$16,818,367
-62.5%
977,812
-63.8%
0.10%
-65.0%
Q1 2023$44,838,521
+58.2%
2,704,374
-27.3%
0.29%
+48.5%
Q4 2022$28,347,048
-23.3%
3,720,085
+0.0%
0.20%
-26.4%
Q3 2022$36,974,000
+9.5%
3,719,666
+0.0%
0.27%
+18.0%
Q2 2022$33,769,000
-10.6%
3,718,964
-0.1%
0.23%
+10.1%
Q1 2022$37,786,000
-39.2%
3,722,680
-0.1%
0.21%
-33.4%
Q4 2021$62,157,000
-64.4%
3,726,388
-0.1%
0.31%
-66.6%
Q3 2021$174,774,000
-23.1%
3,728,904
-0.0%
0.93%
+21.0%
Q2 2021$227,399,000
-0.9%
3,730,302
+0.1%
0.77%
-4.3%
Q1 2021$229,450,000
-3.5%
3,724,834
+11.4%
0.80%
-8.6%
Q4 2020$237,673,000
+29.5%
3,342,334
-40.5%
0.88%
+0.1%
Q3 2020$183,480,000
+0.1%
5,619,928
-0.0%
0.88%
-0.5%
Q2 2020$183,298,000
+6.8%
5,620,919
-5.0%
0.88%
-6.0%
Q1 2020$171,658,000
-27.4%
5,919,246
-12.2%
0.94%
+3.0%
Q4 2019$236,391,000
+63.2%
6,744,392
-0.0%
0.91%
+56.3%
Q3 2019$144,847,000
-20.2%
6,746,511
+0.2%
0.58%
-17.6%
Q2 2019$181,569,0006,732,2440.71%
Other shareholders
BRIDGEBIO PHARMA INC shareholders Q3 2019
NameSharesValueWeighting ↓
Aisling Capital Management LP 6,068,125$55,099,00039.31%
M28 Capital Management LP 466,200$4,233,0004.74%
Kohlberg Kravis Roberts & Co. L.P. 31,060,971$282,034,0003.75%
Octagon Capital Advisors LP 933,743$8,478,0002.26%
VIKING GLOBAL INVESTORS LP 26,620,991$241,719,0001.11%
HHLR ADVISORS, LTD. 5,362,014$48,687,0001.04%
Cormorant Asset Management, LP 1,469,179$13,340,0001.01%
Knott David M Jr 213,206$1,936,0000.81%
Fernwood Investment Management, LLC 183,900$1,670,0000.72%
HighVista Strategies LLC 105,942$962,0000.58%
View complete list of BRIDGEBIO PHARMA INC shareholders